Cut Shape Innovate - MSA · of poly-cotton elements that promotes an accelerated capillary action on wound interfaces.Effectively lifting, transporting and retaining exudate and interstitial

Advanced Wound Care

Vacutex™ incorporates a patented three layer constructionof poly-cotton elements that promotes an acceleratedcapillary action on wound interfaces. Effectively lifting,

transporting and retaining exudate and interstitial fluids.

Cut Shape Innovate

Vacutex A5 18/4/06 14:20 Page 1

nivshenko

New Stamp

featuresVacutex’s capillary action removes potentially bacteria-laden exudate, slough and necrotic debrisaway from the wound bed.Vacutex’s capillary action promotes the migration ofessential cells across the wound bed surface.Vacutex is low adherent and can be customised tosuit the wound.Vacutex is highly absorbent.Vacutex promotes rapid granulation.Vacutex bridges the capabiltiy limitations of manyexisting advanced wound care technologies.

bene tsVacutex’s rapid capillary action promotes optimalmoist wound healing.Vacutex is versatile, easy to use and remove.Vacutex is ective in the management of acute andchronic wound indications.Vacutex has the ability to manage low, moderate andhigh levels of exudate.Vacutex is cost ective.Vacutex prevents maceration to the peri-wound area.

Rapid capillaryaction ‘pulls’interstitial away from thewound bed.

1 Locks andredistributes within a central layer,‘wicking’ laterally untilsaturated.

2 Third layer remainsdry until saturationoccurs withincentral layer.

3

indications for useDiabetic woundsPressure ulcersDehisced surgical woundsLeg ulcersBurns

Product Size DressingsCode (cm) per carton

VAC005005 5 x 5 10VAC010010 10 x 10 10VAC010015 10 x 15 10VAC010020 10 x 20 10VAC015020 15 x 20 10VAC020020 20 x 20 10

VCD010100 10 x 100 5 rollsVCD020100 20 x 100 5 rolls

Distributed by:

Vacutex is a trademark of, and manufactured by Protex Healthcare (UK) Ltd

Protex Healthcare (UK) LtdUnit 5,The Business CentreMolly Millars LaneW okingham, BerkshireRG41 2QZ

telephone: +44 (0) 118 974 0440fax: +44 (0) 118 979 8554e-mail:[email protected]: www.protexhealthcare.com

Man ufactur ed b y:

54 Gibbes St, Chatswood 2067PO Box 764, Willoughby 2068

NSW, Australia

02 9417 795502 9417 5779

[email protected]

NSW, Australia

VCX1000-06 2011

atan

Line

Abdominal Dehiscence

When utilised for the management of abdominaldehiscence, Vacutex™ Advanced Wound Careprovides an effective means of:

Transporting exudates away from the wound site

Managing large volumes of exudates

Protecting surrounding skin from maceration

Promoting rapid granulation

Potentiating reduction in bacterial burden

Providing a simple alternative to negative pressure pumps

Abdominal dehisc A5 18/4/06 12:02 Page 1

1. Deeth, M. Review of an independent audit into the clinicalcacy of Vacutex. British Journal of Nursing, 2002 Vol 11,

No 12.2. Deeth, M. and Pain, L.Vacutex; A dressing designed for

patients,tailored by nurses.British Journal of Nursing, 2001Vol 10, No 4.

Abdominal DehiscenceAbdominal dehiscence can be described as the breakdown and separation of surgicalwound edges, usually due to infection.

Abdominal dehiscence may be either partialor complete.

Abdominal dehiscence may also occurwhere there has been excessive tensionplaced on suture lines.

Generally the wound will begin to breakdown after suture removal and may present with small sinuses that oozepurulent discharge.

Case Study

Dehisced abdominalwound postHartmaan’sprocedure, withwound bed notvisible.

Vacutex rapid capillaryaction dressing wasapplied, wound colourchange and sloughremoval is clearlynoticeable after oneweek. Note wound bedis clearly visible.

Granulation is clearly evident posttwo weeks use ofVacutex rapid capillaryaction dressings.

Wound displayssignificant closure afterthree weeks treatmentwith Vacutex rapidcapillary action dressings.

Pictures taken at weekly intervals.

2

3

4

1



telephone: +44 (0) 118 974 0440fax: +44 (0) 118 979 8554e-mail:[email protected]: www.protexhealthcare.com

Man ufactur ed b y:

VCX1001 06 2011

Heel Pressure Ulcers

When utilised for the management of heelpressure ulcers, Vacutex™ AdvancedWound Care provides an effective means of:

Rapidly debriding full thickness necrotic eschar

Rapidly promotes autolysis of devitalisedtissue and preparation of the wound bed


Alternative to sharp debridement


HeelPressureUlcers A5 18/4/06 12:13 Page 1

1. Lisle, J. Debridement of necrotic tissue and eschar using a capillarydressing and semi-permeable lm dressing. Wound Care,September 2002.

2. Deeth, M. and Pain, L.Vacutex: A dressing designed for patients,tailored by nurses.British Journal of Nursing,2001 Vol 10, No 4.

* Acknowledgement to Dr Linda Russell – Tissue Viability NurseSpecialist – Queens Hospital NHS Trust – Burton-on-Trent



Man ufactur ed b y:

Heel Pressure UlcersPressure ulcers develop as a result of obstructionof blood vessels by unrelieved external pressure.

Moisture and mechanisms such as shear andfriction are often involved in the formation ofpressure ulcers.

These wounds most often manisfest themselves inthe elderly or neurologically compromised patientdue to the reduced ability to reposition.

Grading of pr essur e ulcers

GRADE 1

Non-blanching erythema, discolouration ofthe skin,warmth, oedema, induration orhardness may also be used as indicatorsparticularly on individuals with darker skin.GRADE 2

Partial thickness skin loss or blister,involving epidermis or dermis.GRADE 3

Full thickness skin loss involving damage ornecrosis of subcutaneous tissue which mayextend down to, but not through fascia.GRADE 4

Full thickness skin loss with extensivedestruction, tissue necrosis or damage tomuscle, bone or supporting structure.

Case Study

Heel with signi cantnecrotic eschar visible.Vacutex is capable of‘softening’ the necroticeschar and lifting thedevitalised tissue fromthe wound.

Vacutex’s rapid capillaryaction ‘pulls’anysurrounding slough intothe dressing as theeschar shrinks. In thiscase dressings were cutto a suitable size to coverboth the necrotic andsurrounding area.

Vacutex rapid capillaryaction dressings retainthe exudates and wounddebris within the twolayers of the dressingthus aiding in theprevention of macerationto the surroundinghealthy tissue.

Vacutex rapid capillaryaction dressings havesuccessfully lifted theeschar and clean healthytissue is evident.

Pictures taken at 6 dayintervals*

2

3

4

1

nivshenko

Sticky Note

Unmarked set by nivshenko

Venous Leg Ulcers

When utilised for the management of venous legulcers, Vacutex™ Advanced Wound Careprovides an effective means of:

Removing tenacious slough and necrotic eschar



Managing high volumes of exudates

Employing a dressing suitable for use undercompression bandaging

VenousLegUlcers A5 18/4/06 12:21 Page 1

1. Goldman, R. et al. Measured improvement in rate of healing ofvenous ulceration. British Journal of Nursing, 2003 Vol 12, No 3.

2. Deeth, M. and Pain, L.Vacutex; A dressing designed for patients,tailored by nurses. British Journal of Nursing, 2001 Vol 10, No 4.

3. King, R.Venous leg ulceration and the use of Vacutex. Data on le.

Venous Leg UlcersVenous leg ulceration ects an estimated1-2% of the population and 8% of patients will experience re-occurrence of the disease.

A venous leg ulcer is an irregular shapeddeep or partial thickness wound with wellde ned borders, generally surrounded byhyperpigmented indurated skin.

A yellow/white exudate is often visible.Ulcers vary in size and location, but areusually situated in the gaiter region.

Oedema is common around the ankleregion and pain is usually associated withvenous leg ulceration whether in motion,standing or at rest.

The calf m uscle pump

The calf muscle pump initiates the returnof blood from the lower limbs back to theheart.This mechanism consists of calfmuscles, the deep venous system and thesuperficial venous compartment connectedto deep veins through one way valves viasmaller perforator veins.

Malfunctioning of any of these componentsusually leads to venous ulceration.

Case Study

In this case thereis evidence ofnecrosis,infection,and a sloughyregion to thewound area.

Amputation wasthe probableprognosis for thispatient, clinicianelected to applyVactuex rapidcapillary actiondressings.

Granulation isclearly evidentpost two weeksuse of Vactuexrapid capillaryaction dressings.

Granulation andepithelialisation is clearlyevident post 10 days ofdressing with Vactuexrapid capillary actiondressings.

AMPUTATION WAS AVOIDED.

2

3

4

1



54 Gibbes St, Chatswood 2067PO Box 764, Willoughby 2068

NSW, Australia

02 9417 795502 9417 5779

[email protected]

NSW, Australia

Man ufactur ed b y:

Documents

Cut Shape Innovate - MSA · of poly-cotton elements that promotes an accelerated capillary action on wound interfaces.Effectively lifting, transporting and retaining exudate and interstitial